Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

References

Page 1

	Year	Citations
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, International Journal of Cancer Mortality WorldwideCancer ManagementEpidemiology Of CancerPathologyCancer Incidence	2014	28.8K
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency Dung T. Le, Jennifer N. Uram, Hao Wang, New England Journal of Medicine	2015	9.2K
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova, The Lancet Surgical OncologyChemotherapy Versus ChemotherapyGastrointestinal OncologyMedicineGastroenterology	2010	7.2K
Comprehensive molecular characterization of gastric adenocarcinoma Adam J. Bass, Scott Frazer Nature	2014	6.3K
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMA P Laurén Acta Pathologica Microbiologica Scandinavica So‐called Intestinal‐type CarcinomaEsophageal CancerGastrointestinal OncologyMedicineSurgical Pathology	1965	6.1K
ESPEN Guidelines for Nutrition Screening 2002 Jens Kondrup Clinical Nutrition ObesityNutritionNutritional EpidemiologyClinical NutritionPublic Health Nutrition	2003	3.1K
The global health burden of infection‐associated cancers in the year 2002 Donald Maxwell Parkin International Journal of Cancer Several Infectious AgentsEpidemiology Of CancerImmunologyPathologyRelative Risk	2006	2.9K
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial H. Wilke, Kei Muro, Eric Van Cutsem, The Lancet Oncology Surgical OncologyGastrointestinal OncologyMedicinePaclitaxel Versus PlaceboGastroenterology	2014	2.4K
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer David Cunningham, Naureen Starling, Sheela Rao, New England Journal of Medicine	2008	2.3K
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial Yoon‐Koo Kang, Narikazu Boku, Taroh Satoh, The Lancet Esophageal CancerGastrointestinal OncologyLeast TwoMedicineGastroenterology	2017	2.2K

Page 1